Home / Inspections / 807491

FDA Inspection 807491 — Janssen Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc — FEI 2242843

The FDA completed an inspection of Janssen Pharmaceuticals, Inc on November 16, 2012 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 16, 2012
Fiscal Year
2013
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Titusville, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1271223 (NAI Thu Aug 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229931 (VAI Fri Sep 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131617 (NAI Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131381 (NAI Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031605 (NAI Fri Oct 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources